Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®

NCT01243892 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT01243892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01243892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Open Label, Multicenter, Case-controlled Study of Growth in Patients Using the Nutropin AQ® Nuspin®
Lead sponsor
Genentech, Inc.
Phase
Observational
Overall status
Terminated
Start date
November 30, 2010
Completion date
August 31, 2011
Enrollment
18 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency